Involvement of survival motor neuron (SMN) protein in cell death

Human Molecular Genetics

Volumn 11, Issue 22, 2002, Pages 2751-2764

  Vyas, Sheela ^a   Béchade, Catherine ^a   Riveau, Béatrice ^a   Downward, Julian ^b   Triller, Antoine ^a  

^a INSERM   (France)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CELL PROTEIN; CYTOCHROME C; ETOPOSIDE; PROTEIN BCL 2; SURVIVAL MOTOR NEURON PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL LABELING; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; COILED BODY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME RELEASE; EXON; FLUORESCENCE ANALYSIS; GENE DELETION; HEREDITARY SPINAL MUSCULAR ATROPHY; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; NUCLEOLUS; ONCOGENE C MYC; POINT MUTATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTO ONCOGENE; RAT; ULTRAVIOLET RADIATION;

ANIMALIA;

EID: 0037109143     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.22.2751     Document Type: Article

References (63)

1. Melki, J. (1997) Spinal muscular atrophy. Curr. Opin. Neurol., 10, 381-385.
2. Peam, J. (1980) Classification of spinal muscular atrophies. Lancet, i, 919-922.
3. DiDonato, C.J., Ingraham, S.E., Mendell, J.R., Prior, T.W., Linard, S., Moxley, R.T., Florence, J. and Burghes, A.H.M. (1996) Deletion and conversion in SMA patients: Is there a relationship to severity? Ann. Neurol., 41, 230-237.
4. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M. et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell, 80, 155-165.
5. Parsons, D.W., McAndrew, P.E., Monani, U.R., Mendell, J.R., Burghes, A.H.M. and Prior, T.W. (1996) An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence as the primary SMA-detennining gene. Hum. Mol. Genet., 5, 1727-1732.
6. Coovert, D.D., McAndrew, P.E., Strasswimmer, J., Craford, T.O., Mendell, J.R., Coulson, S.E., Androphy, E.J., Prior, T.W. and Burghes, A.H.M. (1997) The survival motor neuron protein in spinal muscular arophy. Hum. Mol. Genet., 6, 1205-1214.
7. Gavrilov, D., Shi, X., Daas, K., Gilliam, T.C. and Wang, C.H. (1998) Differential SMN2 expression associated with SMA severity. Nat. Genet., 20, 230-231.
8. Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont O., Munnich, A., Dreyfuss, G. and Melki, J. (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet., 16, 265-269.
9. Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C.H. and Li, H. (2000) A mouse model for spinal muscular atrophy. Nat. Genet., 1, 66-70.
10. -/-mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet., 9, 333-339.
11. Jabloka, S., Schrank, B., Kralewski, M., Rossoll, W, and Sendtner, M. (2000) Reduced survival motor neuron (SMN) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. Hum. Mol. Genet., 9, 341-346.
12. Frugier, T., Tiziano, F.D., Cifuentes-Diaz, C., Miniou, P., Roblot, N., Dierich, A., Meur, M.L. and Melki, J. (2000) Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum. Mol. Genet, 9, 849-858.
13. Terns, M.P. and Terns, R.M. (2001) Macromolecular complexes: SMN-the master assembler. Curr. Biol., 11, R862-R864.
14. Liu, Q. and Drefuss, G. (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J, 15, 3555-3565.
15. Liu, Q., Fischer, U., Wang, F. and Dreyfuss, G. (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell, 90, 1013-1021.
16. Pellizzoni, L., Charroux, B. and Dreyfuss, G. (1999) SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc. Natl Acad. Sci. USA, 96, 11167-11172.
17. Pellizzoni, L., Charroux, B., Rappsilber, J., Mann, M. and Dreyfuss, G. (2001) A functional interaction between the survival motor neuron complex and RNA polymerase II. J. Cell Biol., 152, 75-85.
18. Hebert, M.D., Szymczyk, P.W., Shpargel K.B. and Matera, A.G. (2001) Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Genes Dev., 15, 2720-2729.
19. Tucker, K.E., Berciano, M.T, Jacobs, E.Y., LePage, D.F., Shpargel, K.B., Rossire, J.J., Chan, E.K..L., Lafarga, M., Conlon, R.A. and Matera, A.G. (2001) Residual Cajal bodies in coilin knockout fail to recruit Sm snRNPs and SMN, the spinal muscular atrophy gene product. J. Cell Mol., 154, 293-307.
20. Gangwani, L., Mikrut, M., Theroux, S., Sharma, M. and Davis, R.J. (2001) Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein. Nat. Cell Biol., 3, 376-383.
21. Béchade, C., Rostaing, R, Cisterni, C., Kalisch, R., LaBella, V., Pettmann, B. and Triller, A. (1999) Subcellular distribution of survival motor neuron (SMN) protein: possible involvement in nucleocytoplasmic and dendritic transport. Eur. J. Neurosci., 11, 293-304.
22. Pagliardini, S., Giavazzi, A., Setola, V., Lizier, C., Luca, M.D., DeBiasi, S. and Battaglia, G. (2000) Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum. Mol. Genet, 9, 47-56.
23. Jablonka, S., Rossoll, W, Schrank, B. and Sendtner, M. (2000) The role of SMN in spinal muscular atrophy. J. Neurol., 247, 137-142.
24. Burlet, P., Huber, C., Bertrandy, S., Ludosky, M.A., Zwaenpoel, I., Clermont, O., Roume, J., Delezoide, A.L., Cartaud, J., Munnich, A. and Lefebvre, S. (1998) The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum. Mol. Genet, 7, 1927-1933.
25. LaBella, V, Cisterni, C., Salaun, D. and Pettman, B. (1998) Survival motor neuron (SMN) protein in rats is expressed as different molecular forms and is developmentally regulated. Eur. J. Neurosci., 10, 2913-2923.
26. Schrank, B., Gotz, R., Gunnersen, J.N., Ure, J.M., Toyka, K.V., Smith, A.G. and Sendtner, M. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA, 94, 9920-9925.
27. Miguel-Aliaga, I., Culetto, E., Walker, D.S., Baylis, H.A., Saftelle, D.B. and Davies, K.E. (1999) The Caenorhabditis elegans orthologue of the human gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability. Hum. Mol. Genet., 8, 2133-2143.
28. Owen, N., Doe, C.L., Mellor, J. and Davies, K.E. (2000) Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein. Hum. Mol. Genetics., 9, 675-684.
29. Paushkin, S., Charroux, B., Abel, L., Perkinson, R.A., Pellizzoni, L. and Dreyfuss, G. (2000) The survival motor neuron protein of Schizosacharomyces pombe. J. Biol. Chem., 275, 23841-23846.
30. Cisterni, C., Kallenbach,.S., Jordier, F., Bagnis, C. and Pettmann, B. (2001) Death of motoneurons induced by trophic deprivation or by excitotoxicity is not prevented by overexpression of SMN. Neurobiol. Dis., 8, 240-251.
31. Iwahashi, H., Eguchi, Y, Yasuhara, N., Hanafusa, T., Matsuzawa, Y. and Tsujimoto, Y. (1997) Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature, 390, 413-417.
32. Kerr, D.A., Nery, J.P., Traystamn, R.J., Chan, B.N. and Hardwick, J.M. (2000) Survival motor neuron protein modulates neuron-specific apoptosis. Proc. Natl Acad. Sci USA, 97, 13312-13317.
33. Michel, P.P., Vyas, S. and Agid, Y. (1995) Synergistic differentiation by chronic exposure to cyclic AMP and nerve growth factor renders PC12 cells totally dependent upon trophic support for survival. Eur. J. Neurosci., 7, 577-586.
34. Evan, G. and Littlewood, T. (1998) A matter of life and cell death. Science, 281, 1317-1322.
35. Stefanis, L., Park D., Yan, C., Farinelli, S., Troy, C., Shelanski, M. and Greene, L. (1996) Action of CPP32-like activity in PC12 cells by withdrawal of trophic support. J. Biol. Chem., 271, 30663-30671.
36. Juin, P., Hueber, A.O., Littlewood, T. and Evan, G.I. (1999) c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev., 13, 1367-1381.
37. Yao, R. and Cooper, G.M. (1995) Requirement for phosphatidylinositol-3-kinase in the prevention of apoptosis by nerve growth factor. Science, 267, 2003-2006.
38. Deveraux, Q.L. and Reed, J.C. (1999) IAP family of proteins-suppressors of apoptosis. Genes Dev., 13, 239-252.
39. Kelekar, A. and Thompson, C.B. (1998) Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol., 8, 324-329.
40. Fearnhead, H.O., Rodriguez, J., Govek, E.-E., Guo, W, Kobayashi, R., Hannon, G. and Lazebnik, Y.A. (1998) Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl Acad. Sci. USA, 95, 13664-13669.
41. Evan, G.I. and Vousden, K.H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 342-348.
42. Eizenberg, O., Faber-Elman, A., Gottleib, E., Oren, M., Rotter, V. and Schwartz, M. (1996) p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell Biol., 16, 5178-5185.
43. Young, P.J., Day, P.M., Zhou, J., Androphy, E.J., Morris, G.E. and Lorson, C.L. (2002) A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. J. Biol. Chem., 277, 2852-2859.
44. Vyas, S., Faucon Biguet, N., Michel, P.P., Monaco, L., Foulkes, N., Evan, G.I., Sassone-Corsi, P. and Agid, Y. (2002) Molecular mechanisms of neuronal death: unplications for nuclear factors responding to cAMP and phorbol esters. Mol. Cell Neuro. Sci., in press.
45. Li, P., Nijhawan, D., Budihardjo, I., Srinivsula, S., Ahmad, M., Alnemeri, E. and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase9 initiates an apoptotic protease cascade. Cell, 91, 479-489.
46. Kirsch, D.G., Doseff, A., Chan, B.N., Lim, D.S., Souza-Pinto, N.C.D., Hansford, R., Kastan, M.B., Lazebnik, Y.A. and Hardwick, J.M. (1999) Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem., 274, 21155-21161.
47. Rokudai, S., Fujita, N., Hashimoto, Y. and Tsuruo, T. (2000) Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis. J. Cell Physiol., 182, 290-296.
48. Littlewood, T., Hancock, D., Danielian, P., Parker, M. and Evan, G. (1995) A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res., 23, 1686-1690.
49. Harrington, E.A., Bennet, M.R., Fanisi, A. and Evan, G.I. (1994) c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J, 13, 3286-3295.
50. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of appptosis in fibroblasts by c-Myc protein. Cell, 69, 119-128.
51. Pellizzoni, L., Kataoka, N., Charroux, B. and Dreyfuss, G. (1998) A novel function for SMN, the spinal muscular atrophy discase gene product, in pre-mRNA splicing. Cell, 95, 615-624
52. Wang, J. and Dreyfuss, G. (2001) A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemini2 on SMN. J. Biol. Chem., 276, 9599-9605.
53. Thornberry, N.A. and Lazebnik, Y. (1998) Caspases: enemies within. Science, 281, 1312-1316.
54. Soengas, M.S., Alarcon, R.M., Yoshida, H., Giaccia, A.J., Hakem, R., Mak, T.W. and Lowe, S.W. (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science, 284, 156-159.
55. Vogelstein, B., Lane, D. and Levine, A.J. (2000) Surfing the p53 network. Nature, 409, 307-310.
56. Lorson, C.L., Hahnen, E., Androphy, E.J. and Wirth, B. (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA, 96, 6307-6311.
57. Monani, U.R., Lorson, C.L., Parsons, D.W., Prior, T.W., Androphy, E.J., Burghes, A.H.M. and McPherson, J.D. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet, 8, 1177-1183.
58. Campbell, L., Potter, A., Ignatius, J., Dubowitz, V. and Davies, K. (1997) Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am. J. Hum. Genet., 61, 40-50.
59. Lorson, C.L. and Androphy, E.J. (2000) An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum. Mol. Genet., 9, 259-265.
60. Cifuentes-Diaz, C., Frugier, T, Tiziano, F.D., Lacène, E., Roblot, N., Joshi, V, Moreau, M.-H. and Melki, J. (2001) Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J. Cell Biol., 152, 1107-1114.
61. Lorson, C.L., Strasswimmer, J., Yao, J.-M., Baleja, J.D., Hahnen, E., Wirth, B., Le, T., Burghes, A.H.M. and Androphy, E.J. (1998) SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat. Genet., 19, 63-66.
62. Rohn, J.L., Huber, A.-O., McCarthy, N.J., Lyon, D., Navarro, P., Burgering, B.M.T. and Evan, G.I. (1998) The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis. Oncogene, 17, 2811-2818.
63. Littlewood, T., McCarthy, N., Whyte, M., Pelengaris, S., James, C. and Evan, G. (1996) Controllable genetic manipulation of apoptosis of cells in culture. Cytotechnology, 22, 157-167.